FDA Clears Six New Interventional Systems for Siemens’s Optiq AI Imaging Chain

May 13, 2026—Siemens Healthineers announced it has received FDA clearance for six new systems in its Artis interventional imaging portfolio, all of which feature the company’s new artificial intelligence (AI)–powered imaging chain, Optiq AI, to analyze and optimize image data in real time.

According to Siemens, the new interventional systems include the floor, biplane, ceiling, and pheno (or floor-mounted robotic) versions of the Artis vision platform; as well as the floor configurations of the Artis icono.explore and Artis genio platforms. The company stated that the four systems in the Artis vision platform deliver high speed and precision for image-guided procedures. The floor version of the Artis icono.explore is engineered for high patient throughput, and the Artis genio floor is a workhorse system designed for versatility and high productivity to handle a broad case mix.

The Optiq AI imaging chain is intended to provide precision and premium image quality for image-guided procedures. Optiq AI applies deep-learning-based noise reduction to two-dimensional imaging modalities such as fluoroscopy, acquisition, and digital subtraction angiography. This denoising enables consistent, high-quality visualization during interventional procedures, noted Siemens Healthineers.